Clinical Trial Update: A Prospective, Observational Study to Assess and Evaluate the Use of Glucophage XR Therapy in the Management of Patients With Type 2 Diabetes

View source ↗

Summary

A prospective observational study evaluating Glucophage XR for the management of Type 2 Diabetes Mellitus has completed. The sponsor is Merck KGaA, Darmstadt, G…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucophage XR (metformin hydrochloride extended-release)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED